C2623 HCPCS Level II code: Catheter, transluminal angioplasty, drug-coated, non-laser

C2623 is the HCPCS code for “Catheter, transluminal angioplasty, drug-coated, non-laser” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

C2623

Catheter, transluminal angioplasty, drug-coated, non-laser

Short description: Cath, translumin, drug-coat

HCPCS · United States

Medicare details

The indicators CMS publishes with C2623 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Statute
Type of service
Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
BETOS category
Medical/surgical supplies
Coverage statute
1833(t)
Added
Apr 1, 2015

Where C2623 sits

  1. 1C codesOutpatient prospective payment system
  2. 2Active code C2623Catheter, transluminal angioplasty, drug-coated, non-laser

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code C2623 mean?

C2623 is the HCPCS code for “Catheter, transluminal angioplasty, drug-coated, non-laser” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover C2623?

CMS lists C2623’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.